Gulf War Syndrome - A model for the complexity of biological and environmental interaction with human health

Adverse Drug Reactions and Toxicological Reviews

Volumn 17, Issue 1, 1998, Pages 1-17

  Jamal, Goran A ^a  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

Anticholinesterases; Blood brain barrier; c Fos oncogene; Chemical warfare agents; Chlorpyrifos; Deet; Depleted uranium; EMG; Gulf war syndrome; Immune system; NAPS; Nerve conduction; Neurobehavioural; Organophosphates; Permethrin; Plasmid DNA; Post traumatic stress disorder; Pyridostigmine bromide; Stress; Vaccination

Indexed keywords

CHEMICAL WARFARE AGENT; INSECT REPELLENT; ORGANOPHOSPHATE; PESTICIDE; PYRIDOSTIGMINE; URANIUM; VACCINE;

ARTHRALGIA; BEHAVIOR DISORDER; BLADDER DYSFUNCTION; DIARRHEA; ENVIRONMENTAL FACTOR; FATIGUE; GASTROINTESTINAL SYMPTOM; HUMAN; MUSCULOSKELETAL DISEASE; MYALGIA; PERSIAN GULF SYNDROME; PROPRIOCEPTION; RESPIRATORY TRACT DISEASE; REVIEW; SENSORY DYSFUNCTION; SKIN MANIFESTATION; SOLDIER; SWEATING; SYMPTOM; WAR;

CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; ENVIRONMENTAL EXPOSURE; HUMANS; MILITARY PERSONNEL; OCCUPATIONAL EXPOSURE; PERSIAN GULF SYNDROME; PYRIDOSTIGMINE BROMIDE; RISK FACTORS; VACCINATION; VETERANS;

INSECTA;

EID: 0031778449     PISSN: 0964198X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. NIH Technology Assessment Workshop Panel: The Persian Gulf experience and health. JAMA 1994; 272: 391-6.
2. Royal College of Physicians. RCP audit of Gulf War Medical Assessment Program. Ministry of Defence. UK, July 1995.
3. Editorial. Bridging the Gulf. Lancet 1996; 347: 341.
4. Institute of Medicine. Health Consequences, of Service During Persian Gulf War: Recommendations for Research and Information Systems. 1996, National Academic Press: Washington DC.
5. News. Gulf War research given go ahead. BMJ 1997; 314: 95.
6. US General Accounting Office. Gulf War Illnesses Improved Monitoring of Clinical Progress and Re-examination of Research emphasis are needed. June 1997.
7. Borland RG, Breman DH, Nicholson AN. Studies on possible central and peripheral effects in man of a cholinesterase inhibitor (pyridostigmine). Hum Toxicol 1985; 4: 293-300.
8. Taylor P. Cholinergic Agonists and anticholinesterase agents. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics. 8th edition, New York: Pergamon, 1990: 122-47.
9. Sharabi Y, Danon YL, Berkenstadt H. Survey of symptoms following intake of pyridostigmine during the Persian Gulf War. Israeli J Med Sci. 1991; 27: 656-8.
10. Persian Gulf Veterans Co-ordinating Board. Unexplained illnesses among Desert Storm veterans: a search for causes treatment and co-operation. Arch Int Med. 1995; 155: 262-8.
11. Abou-Donia MB, Wilmarth K R, Jensen KJ, Oehme FW, Kurt TL. Neurotoxicity resulting from co-exposure to pyridostigmine bromide, DEET, and Permethrin: implications of Gulf War chemical exposures. J Toxicol Environ Health 1996; 48: 35-56.
12. Abou-Donia M, Wilmarth KR, Abdel-Rahman A, Jensen KF, Oeheme FW, Kurt TL. Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos. Fundam Appl Toxicol 1996; 34: 201-22.
13. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq, Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nature Medicine 1996; 2: 1382-5.
14. Whittaker M. Cholinesterases. Monog Hum Genet 1986: 65-8.
15. Schwarz M, Glick D, Loewenstein Y, Soreq H. Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisons. Pharmacol Ther 1995; 67: 283-321.
16. Pope CN, Padilla S. Potentiation of organophosphorus delayed neurotoxicity. J Toxicol Environ Health 1990; 31: 261-73.
17. Tuite J. Testimony to the Presidential Advisory Committee on Gulf War Veterans' illnesses April 1996. Atlanta, GA.
18. Ballantyne JP, Hansen S. Computer method for the analysis of evoke motor unit potentials. Control subjects and patients with myasthenia gravis. J Neurol Neurosurg Psychiat 1974; 37: 1187-94.
19. Hubert M, Lison D. Study of muscular effects of short-term pyridostigmine treatment in resting and exercising rats. Hum Exp Toxicol 1995; 14: 49-54.
20. Jamal GA, Hansen S, Apartopoulos F, Peden A. The 'Gulf War Syndrome'. Is there evidence of dysfunction in the nervous system? J Neurol Neurosurg Psychiat 1996; 60: 449-51.
21. Jamal GA. Gulf War Syndrome. Biologist 1996; 43: 98-9.
22. Hudson CS, Foster RE, Kahng MW. Neuromuscular toxicity of NAPS in the diaphragm, extensor digitorum longus. and soleus muscles of the rat. Fundam Appl Toxicol 1985; 5: S260-S269.
23. Loewenstein-Lichtenstein Y, Schwarz M, Glick D, Norgaard-Pedersen B, Zakut H, Soreq H. Genetic predisposition to adverse consequences of anticholinesterases in 'atypical' BCHE carriers. Nature Medicine 1996; 10: 1082-5.
24. Johnson MK. A phosphorylation site in brain and the delayed neurotoxic effects of some organophosphate compounds. Biochem J 1969; 111: 487-95.
25. Jamal GA. Neurological syndromes of organophosphorus compounds. Adverse Drug React Toxicol Rev 1997; 16: 133-70.
26. Chancy LA, Mozingo JR, Hume AS, Moss JI. Potentiation of NAPS toxicity in mice by selected adrenergic agents and caffeine. Vet Human Toxicol. 1997; 39: 214-9.
27. Gouge SF, Daniels DJ. Exacerbation of asthma after pyridostigmine during Operation Desert Storm. Mil Med. 1994; 159: 108-11.
28. Arnold SF, Klotz DM, Collins BM, Vonier PM, Guillette LJ, McLachlan JA. Synergestic activation of oestrogen receptor with combinations of environmental chemicals. Science 1996; 272: 1489-92.
29. Ben-Nathan D, Lusting S, Danenberg HD. Stress-induced neuroinvasiveness of a neurovirulent non invasive sindbis virus in cold or isolation subjected mice. Life Sci 1991; 48; 1493-500.
30. Amato AA, McVey A, Cha C, et al. Evaluation of neuromuscular symptoms in veterans of the Persian Gulf War. Neurology 1997; 48: 4-12.
31. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. 2nd edition, Philadelphia: F.A. Davis, 1988.
32. Jamal GA, Weir AI, Hansen S, Ballantyne JP, Myotonic dystrophy. A reassessment by conventional and more recently introduced neurophysiologjcal techniques. Brain 1986; 109: 1279-96.
33. Stalberg E, Trontelj JV. Single Fibre Electromyography. 2nd edition, New York: Raven Press, 1994.
34. Haley RW, Kurt T, Horn J. Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms. JAMA 1997; 227: 215-22.
35. Haley RW, Horn J, Roland PS, et al. Evaluation of neurologic function in Gulf War Veterans. JAMA 1997; 277: 223-30.
36. Haley RW, Kurt TL. Self-reported exposure to neurotoxic chemical combinations in the Gulf War. A cross-sectional epidemiologic study. JAMA 1997; 227: 231-7.
37. Mandelson G. Chronic pain, compensation and clinical knowledge. Theor Med 1991; 12: 227-46.
38. Levy A. Compensation neurosis rides again. Brain Inj 1992; 6: 401-10.
39. Landrigan PJ. Illness in Gulf War Veterans. Causes and consequences. JAMA 1997; 227: 259-61.
40. The Iowa Persian Gulf Study Group. A population based study. JAMA 1997; 227: 238-45.
41. Ronald PS, Haley RW, Yellin W, Owens K. Vestibular dysfunction in Gulf War Syndrome. Otolaryngology Head & Neck Surgery, 1998 (in press).
42. Rook GAW, Zumla A. Gulf War Syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile? Lancet, 349: 1831-3.
43. Casale GP, Vennerstrom JL, Bavari S, Wang TL. Inhibition of interleukin-2 driven proliferation of mouse CTLL2 cells, by selected carbamate and organophosphate insecticides and congeners of carbaryl. Immunopharmacol Immunotoxicol 1993; 15: 199-215.
44. Smit JA, Stark JH, Myburgh JA. Induction of primate Th2 lymphokines to suppress Th1 cells. Transplant Proc 1996; 28: 665-6.
45. Mu HH, Sewell WA. Enhancement of interleukin - 4 production by pertussis toxin. Infect Immun 1993; 61: 2834-40.
46. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann. Establishment of stable cell mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 1992; 257: 539-42.
47. Hernandez-Pando R, Rook GAW. The role of TNFα in T-cell medicated inflammation depends on the Th1 Th2 cytokine balance. Immunology 1994; 82: 591-5.
48. Brenton E, Hoover D, Galloway R, Popp K. Adapation to chronic stress in military trainees: adrenal androgens, testosterone, glucocorticoids. IGF-1 and immune function. Ann NY Acad Sci 1995; 774: 217-31.
49. Brinkmann V, Kristofic C. Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO- and CD45RO+ subjects. J Immunol 1995; 155: 3322-8.
50. Raminez F, Fowell DJ, Puklavec M, Simmonds S, Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 1996; 156: 2406-12.
51. Straus S. Chronic fatigue syndrome. In: Saul R. ed. Medicine for the Public. Bethesda MD: National Institutes of Health. 1996. NIH Publication number, 90-3059: 1-5.
52. Presidential Advisory Committee on Gulf War Veterans' Illnesses: Final report. Washington, DC: US GPO, 1996.
53. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th version (DSM-IV-R). Washington, DC: American Psychiatric Association, 1994.
54. Haley RW. Is Gulf War Syndrome due to stress? The evidence reexamined. Am J Epidemiol 1997; 146: 695-703.
55. Ministry of Defence UK. Government reply to 11th report from the Defence Select Committee Session 1994-1995 on Gulf War Syndrome, 30 January 1996.
56. Department of Defense USA. Comprehensive clinical evaluation program for Persian Gulf War Veterans. 2 April, 1996.